Ethical Compliance
NEULAND LAB.
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
medium
Revenue
0.5%
Debt
4.5%
Liquidity
6.4%
Revenue
Debt
Liquidity
0.5%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Impurities | ₹1.32 |
| Sale of Scrap | ₹17.55 |
| Export Incentives | ₹24.06 |
| Other Income | ₹4.32 |
| Sale of Pharmaceuticals Products | ₹1,447.48 |
| Job Work Income | ₹68.19 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹8.23 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹8.23 |
| Total: | ₹8.23 |
| Total Revenue: | ₹1,571.12 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹8.23
₹1,571.12
= 0.5%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
